The World Health Organization has approved another COVID-19 vaccine for emergency use listing. Corbevax was developed by scientists at the Texas Children’s Hospital and the Baylor College of Medicine. In a press release, Texas Children’s Hospital said that 100 million doses of Corbevax have been administered in India.
Editor’s Note: Many questions arise from this article. First of all, how is the WHO able to add Corbevax to the “emergency listing” when there is no emergency? [See Is the COVID pandemic over? and this New York Times article announcing the end of the COVID ‘pandemic’].
How was the WHO able to add a new COVID shot as an “emergency” drug if the immune system is proven to be more effective than any vaccine? [See Study: Natural Immunity More Effective Protection Than Vaccine].
Why does the WHO need to add a new COVID shot to the emergency listing when no one wants the boosters? [Read this article published by the National Library of Medicine. Also, read this CNN article showing that fewer young people are taking the COVID booster shots.]
Read Original Article
Click the button below if you wish to read the article on the website where it was originally published.
Click the button below if you wish to read the article offline.